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Background: High-intensity focused ultrasound is a valuable tool for minimally invasive tumour ablation. However,
due to the air content in ventilated lungs, lung tumours have never been treated with high-intensity focused
ultrasound. Lung flooding enables efficient lung sonography and tumour imaging in ex vivo human and in vivo
porcine lung cancer models. The current study evaluates the effectiveness of lung flooding and sonography-guided
high-intensity focused ultrasound for lung tumour ablation in ex vivo human and in vivo animal models.
Methods: Lung flooding was performed in four human lung lobes which were resected from non-small cell lung
cancers. B-mode imaging and temperature measurements were simultaneously obtained during high-intensity
focused ultrasonography of centrally located lung cancers. The tumour was removed immediately following
insonation and processed for nicotinamide adenine dinucleotide phosphate-diaphorase and H&E staining. In
addition, the left lungs of three pigs were flooded. Purified BSA in glutaraldehyde was injected centrally into the left
lower lung lobe to simulate a lung tumour. The ultrasound was focused transthoracically through the flooded lung
into the simulated tumour with the guidance of sonography. The temperature of the tumour was simultaneously
measured. The vital signs of the animal were monitored during the procedure.
Results: A well-demarcated lesion of coagulation necrosis was produced in four of four human lung tumours.
There did not appear to be any damage to the surrounding lung parenchyma. After high-intensity focused
ultrasound insonation, the mean temperature increase was 7.5-fold higher in the ex vivo human tumour than in the
flooded lung tissue (52.1 K ± 8.77 K versus 7.1 K ± 2.5 K). The transthoracic high-intensity focused ultrasound of
simulated tumours in the in vivo model resulted in a mean peak temperature increase up to 53.7°C (±4.5). All of the
animals survived the procedure without haemodynamic complications.
Conclusions: High-intensity focused ultrasound with lung flooding produced a thermal effect in an ex vivo human
lung carcinoma and in vivo simulated lung tumours in a porcine model. High-intensity focused ultrasound is a
potential new strategy for treating lung cancer.
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Lung cancer remains the leading cause of cancer-related
death in the western population [1,2]. In addition to pri-
mary tumours, the lung is the most common site for
metastatic spread of other malignancies. Curative treat-
ment of lung tumours or metastases requires surgical
resection, which results in the loss of functional lung
parenchyma. Unfortunately, fewer than half of patients
are eligible for curative surgery due to limited lung func-
tion [3]. Radiation or chemotherapy alone rarely cures
patients. Minimally invasive local ablation (for example,
percutaneous laser or radiofrequency) results in major
complications in 6% of patients and procedure-specific
30-day mortality rates of 2.6% [4]. Furthermore, the local
progression rate is 35% [5]. Therefore, these procedures
are palliative strategies.
High-intensity focused ultrasound (HIFU) is a non-
invasive, highly precise procedure to locally destroy
tissue through ablation. Current clinical trials are eva-
luating the effectiveness of HIFU for the treatment of
cancers of the brain, breast, liver, bone, and prostate
[6-9]. However, lung cancers have never been treated
with this approach, because the ventilated lung is a total
acoustic absorber and reflector [10]. This problem was
solved by lung flooding. Lung flooding enables efficient
lung sonography and tumour imaging in ex vivo human
and in vivo porcine lung cancer models [11]. The condi-
tions for applying HIFU to lung tumours are provided.
The aim of this study was to evaluate the effectiveness
of sonography-guided HIFU with lung flooding for lung




Preparation of resected human lung lobes with carcinoma
Four patients with non-small cell lung cancer (NSCLC)
received therapeutic lobectomies of the right lower lobe
(n = 2), right upper lobe (n = 1), or left lower lobe (n = 1).
The average age of the patients was 75.7 years (range 68
to 82 years). The mean tumour diameter was deter-
mined by computed tomography and was 4.1 cm (range
3.2 to 5.1 cm). Pre-surgical histological diagnoses of
three adenocarcinomas and one large cell neuroendo-
crine carcinoma were confirmed with percutaneous or
transbronchial needle biopsies. The lobes were cooled in
a 15°C isotonic liquid bath immediately following resec-
tion and prepared for liquid filling (flooding) in tabula.
An expanded polytetrafluoroethylene graft was then
anastomosed end-to-end with the lobar bronchi. An
infusion system was connected to the conduit, and the
lobes were continuously filled with isotonic saline (15°C)
until the functional residual capacity was reached. The
lung lobe was examined transpleurally by ultrasound(MicroMaxx™ Portable Ultrasound System; SonoSite,
Inc., Bothell, WA, USA) in the liquid bath with a linear
probe (L38e, 10 to 5 MHz; SonoSite, Inc., Bothell, WA,
USA) in fundamental B-mode. The lobes were selected
for HIFU only in cases with gas-free filling and complete
sonographic imaging of the tumour. This study was
approved by the ethics committee of the Medical Associ-
ation of Thuringia.
HIFU application
The experimental HIFU setup contained the HIFU trans-
ducer H102 (Sonic Concepts Inc., Bothell, WA, USA), a
power amplifier (RF Source, Athena, Greece), a Type K
thermocouple (XF339, Labfacility Ltd., Sheffield, South
Yorkshire, UK), and a digital multimeter (34401A, Agilent,
Santa Clara, CA, USA). The HIFU setup and alignment
with the tumour are illustrated in Figure 1. The thermo-
couple was guided through the centre hole of the HIFU
transducer into the tumour. The alignment of the HIFU
focal zone within the tumour and the thermocouple was
monitored by ultrasound with a curved imaging probe
(C11e, SonoSite, Inc., Bothell, WA, USA), which was
mounted sideways on the HIFU transducer. Self-heating
of the thermocouple was excluded by applying HIFU to
the thermocouple in water. An impedance-matching net-
work provided by the manufacturer drives the HIFU
probe with a radiofrequency (RF) amplifier. The acoustic
power of the focal zone in water was estimated to be
2,500 W/cm2 at 1.1 MHz (ISPTP, spatial peak, temporal
peak) based on the manufacturer’s calibration sheet. A
duty cycle of 50% and a repetition frequency of 10 KHz
were applied. The cancer tissue was exposed to HIFU for
ten seconds. The focal zone was immediately moved
through the tumour in lateral 2 mm increments. HIFU
was initiated again for ten seconds, and ultrasound B-
mode imaging was then performed. HIFU exposure ended
after one slice of the HIFU zone moved through the
tumour volume. Subsequently, the HIFU focus and
thermocouple were placed into flooded lung tissue. The
procedure was repeated as described above. All experi-
mental steps were performed within 45 minutes of surgi-
cal resection.
Histopathology and enzyme histochemistry
The specimen, including the tumour, was cut at a 90°
angle to the treated cross section immediately following
the last HIFU exposure. Each half of the tumour was
sectioned parallel to the cutting surface to show the
transition from ablated to non-ablated tumour. One part
was fixed in 4% formaldehyde for H&E, and the other
was frozen in liquid nitrogen for nicotinamide adenine
dinucleotide phosphate (NADPH)-diaphorase staining.
An intralobar metastasis from one case served as an
untreated tissue control.
Figure 1 Schematic setup of ex vivo high-intensity focused ultrasound application. High-intensity focused ultrasound transducer (1),
flooded lung (2), cancer (3), attenuator (4), impedance matching network (5), power RF amplifier (6), signal generator (7), thermocouple (8),
multimeter (9), thermo-control (10), and sector-array probe (11).
Figure 2 In vivo high-intensity focused ultrasound application
after rib resection. Thermocouple (1), high-intensity focused
ultrasound transducer (2), and sector-array probe (C11e, 8 to 5 MHz,
Micromaxx, Sonosite Inc., Bothell, WA, USA) (3).
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Animal preparation
Animal experiments were performed on three female
pigs (Deutsches Landschwein breed; weight range: 33 to
38 kg, average: 35.5 kg) with permission from the Veter-
inary Department of the Thuringian State Authority for
Food Protection and Fair Trading in compliance with
the National Animal Protection Act. Total intravenous
anaesthesia was initiated with propofol (10 mg/kg/h),
fentanyl (0.05 to 0.08 μg/kg/min), and pancuronium
bromide (2.5 μg/kg/min). A left-sided Robertshaw double-
lumen tube with an extra-long bronchial lane (size 39 Ch;
special product by Mallinckrodt Medical, Dublin, Ireland)
was inserted after tracheotomy. Mechanical ventilation
was performed with an ICU respirator (Servo 900,
Siemens AG, Munich, Germany) on a volume-controlled
setting (FIO2 = 1.0; tidal volume 10 ml/kg; respiratory rate
16 to 20/min; positive end expiratory pressure = 6 cm
H2O). The electrocardiogram, arterial blood pressure,
capillary oxygen saturation, and expiratory CO2 con-
centration were measured and recorded continuously
(Datex AS/3 Compact Multiparameter Patient Monitor;
Datex-Ohmeda Corp., Helsinki, Finland). Arterial blood
gases were analysed every 30 minutes (ABL System 625;
Radiometer Medical, Copenhagen, Denmark).
Tumour simulation and HIFU application
The HIFU setup for transthoracic application on pigs
contained a self-manufactured sample holder. The HIFU
transducer (SU102, Sonic Concepts Inc., Bothell, WA,
USA) was arranged with the sideways attached puncture
channel to guide the thermocouple and curved imaging
probe (C11e, MicroMaxx; SonoSite Inc., Bothell, WA,
USA). The three elements were arranged such that the
thermocouple tip was in the focus of the HIFU beam. Arib was resected after lung flooding without pleural
injuries. The HIFU applicator was placed above the
resected rib (Figure 2). A 17-G needle was placed in the
centre of the lower left lung lobe with the guidance of a
percutaneous transpleural ultrasound. Five millilitres of
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(Bioglue®; CryoLife Europa, Guildford, UK) were injected
to simulate a lung tumour. A thermocouple was imme-
diately inserted through the needle into the simulated
tumour. The alignment of the focal zone with the target
lesion and thermocouple was monitored by ultrasound
imaging. The surgical HIFU probe with an outer diam-
eter of 35 mm operates at 3.0 MHz. The focal acoustic
intensity was estimated to be 2,000 W/cm2 MHz (ISPTP,
spatial peak, temporal peak) based on the manufacturer’s
calibration sheet. HIFU was applied according to a ‘one
second on, one second off ’ scheme. The temperature
inside the simulated tumour was recorded by the
thermocouple during HIFU exposure. Data were trans-
ferred and stored on a laptop.
Results
Ex vivo examinations
The mean temperature in the tumour tissue increased
by 52.1 K ± 8.77 K after ten seconds of HIFU exposure.
The same acoustic intensity produced a mean tempe-
rature increase of 7.1 K ± 2.5 K in a flooded lung. The
temperature increase in the ex vivo human NSCLC was
7.5-fold higher than that in the flooded lung tissue
(Figure 3). The sonoablated cancer tissue appeared to be
strongly hyperechoic immediately following HIFU appli-
cation (Figure 4). The strength of echogenicity decreased
30 seconds after HIFU exposure but did not disappear.
The ablated cancer tissue appeared to be slightly whitishFigure 3 Mean temperature increase. The mean temperature increases (
flooded lung tissue (n = 3) and within flooded lung alone (n = 3) are shown
after ex vivo high-intensity focused ultrasound insonation.in all four cases. A demarcation between treated and
non-treated areas was observed (Figure 5).
H&E staining showed coagulative necrosis with cyto-
plasmic eosinophilia, disruption of cellular membranes
with blurred cytoplasmic borders, karyolysis, and nuclear
pyknosis. Insonated and non-insonated cancer tissues
showed sharp demarcations. There was a small region
between the area of coagulation necrosis and vital cancer
tissue in which cells showed cytoplasmic vacuolization
(Figure 6). These characteristics were not found in the
untreated areas of cancer tissue. NADPH-diaphorase
staining produced a sharp demarcation between ablated
and non-ablated cancer tissue, and demonstrated that
vital lung tissue was present immediately adjacent to
ablated cancer tissue (Figure 7). HIFU-treated tumour
tissue did not show evidence of vitality by NADPH-
diaphorase staining. Sonographic lesions were not
detected in the tumour surrounding the lung tissue or in
the direction of the HIFU irradiation. In contrast, a non-
treated metastatic tumour in the same lobe showed
complete vitality.
In vivo examination
A lung tumour could be simulated in the flooded lung
of each of the three animals by sonography-guided
injection of BioGlue®. The central tumour appeared
hypoechoic by B-mode sonography and was sharply
demarcated from the lung parenchyma with small inclu-
sions of air. A temperature rise was monitored within± standard deviation) within an adenocarcinoma surrounded with
. Temperatures were measured with a thermocouple ten seconds
Figure 4 Sonomorphology of adenocarcinoma in ex vivo flooded human lung before and after high-intensity focused ultrasound.
(A) B-mode ultrasound image of adenocarcinoma in flooded lung before ex vivo high-intensity focused ultrasound insonation. Adenocarcinoma
(1), flooded lung (2), thermocouple (3), and focal zone of high-intensity focused ultrasound beam (4); (B) B-mode ultrasound image after single
high-intensity focused ultrasound insonation demonstrates a sharply demarcated and strongly hyperechoic sonolesion within the tumour.
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section of 25 seconds of HIFU exposure in the ‘one
second on, one second off ’ scheme is shown in Figure 8.
Repeated HIFU insonation caused an overall average
temperature increase of up to 53.7°C (±4.5, n = 3).
Arterial blood pressure, oxygen, and carbon dioxide
partial pressure were normal in all three animals during
and after HIFU insonation. No animals died during the
procedure.
Discussion
Currently, the best curative treatment for early-stage
non-small cell lung cancer and lung metastases is surgi-
cal resection. However, surgery is not appropriate forpatients with reduced pulmonary function due to the
loss of lung parenchyma. Minimally invasive technolo-
gies for local tumour control have been developed as
alternatives to surgery. The most common method is
percutaneous radiofrequency ablation. However, this
kind of thermal ablation is limited because the extent to
which tissue has been successfully ablated cannot be
accurately assessed. This could be a reason for the
observed rate of local recurrence. Another risk factor for
local tumour progression is the adherence of viable
tumour tissue to needle applicators and subsequent
spreading of tumour cells [12]. In addition, pulmonary
percutaneous radiofrequency ablation is invasive and
associated with major complications and mortality.
Figure 5 Macroscopic appearance of the zone of ablated tumour
tissue (inside the highlighted circle) in the resected specimen.
Arrows show the tumour margin of non-ablated adenocarcinoma.
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clinical trials as a technique for localized tissue ablation
for more than 60 years. HIFU is superior to other radi-
ation beams, because it penetrates deep and selectively
destroys tumour tissue. In addition, HIFU can be applied
as many times as needed [13]. HIFU is currently used as
a therapy for cancers of the abdominal organs, breast,
and brain [14-18].Figure 6 Histological examination of large cell neuroendocrine carcin
application. The border between ablated and non-ablated tumour is show
effect is visible as a small area, which contains cells with cytoplasmic vacuolizat
disruption of cellular membranes with blurred cytoplasmic borders, karyolysis, aNon-invasive local therapies with curative intention
are not available for lung tumours. HIFU has never been
applied to lung tumours, because the air content in
ventilated lungs reflects acoustic intensities. We solved
this problem with lung flooding. Lung flooding enables
efficient lung sonography and tumour imaging in ex vivo
human and in vivo porcine lung cancer models [11]. The
cancerous tissue was visualized by replacing the alveolar
gas with fluid, facilitating ultrasound-guided HIFU. The
aim of the present study was to explore the ability of
therapeutic ultrasound to penetrate the overlying lung
parenchyma without damage and to increase the tem-
perature of the tumour tissue.
A tissue temperature greater than 60°C will usually
cause instantaneous and irreversible cell death within
one second in most extrapulmonary tissues due to co-
agulation necrosis. Coagulation necrosis is the primary
mechanism by which HIFU destroys tumour cells [6].
Our ex vivo studies showed that lung cancer tissue
absorbed acoustic energy, leading to an increase in
tumour temperature of 52.1 K. Based on the temperature
of a cooled lung lobe (15°C), a peak temperature of 67°C
was created. The heat induced by HIFU was sufficient to
generate coagulation necrosis in the lung cancer tissue. In
contrast, the same acoustic HIFU energy caused a min-
imal temperature increase (7.1 K) in flooded parenchyma.oma immediately after ex vivo high-intensity focused ultrasound
n. There is a vital tumour in the upper left image (A). The thermal
ion (B) and as a coagulative necrosis with cytoplasmic eosinophilia,
nd nuclear pyknosis (C). Arrows indicate the sonolesion boundary (H&E).
Figure 7 Nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase staining. There is a sharp demarcation between vital lung
tissue (A) and ablated tumour tissue (B). Immediately after ex vivo high-intensity focused ultrasound application, NADPH-diaphorase staining
showed a lack of uptake of the vitality stain in finger-shaped tumour extensions (B).
Figure 8 Temperature profile inside the simulated target lesion
(BioGlue®). The temperature profile is shown for the simulated
lesion during transthoracic high-intensity focused ultrasound insonation
after in vivo flooding of the left lung of a pig. Temperature increases
were monitored for each one-second treatment with HIFU irradiation.
A section of 25 seconds of HIFU exposure following the ‘one second
on/off’ scheme is demonstrated. The repeated HIFU insonation caused
a temperature increase up to 54°C.
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highly selective for tumour tissue in flooded lungs. The
lung parenchyma directly adjacent to the ablated cancer
tissue was undamaged and viable. This can be explained
by the very low attenuation of saline, which is the major
mass component in flooded lungs [19]. Thus, the risk of
damaging the surrounding tissue or adjacent organs can
be minimised as previously described in a study of HIFU
in abdominal tumours [20]. A normal saline solution was
injected into the abdominal cavity to reduce complications
from HIFU therapy for abdominal tumours. This method
does not have adverse effects on the efficacy of HIFU
ablation [21].
In vivo transthoracic HIFU application in pigs caused
a mean peak temperature increase up to 53.7°C in a
simulated lesion (BioGlue®) deep inside the flooded lung.
HIFU energy penetrated through the pleura and flooded
lung into the target lesion. The simulated lesion, which
was located at a 6 cm depth below the transducer, was
heated by HIFU. The temperature increase was highly
variable and inconstant. The mechanism of heat gener-
ation in the BioGlue®-simulated lesion was unclear. The
lesion consisted of purified BSA and glutaraldehyde.
Although this simulated lesion was not a true human
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to those of human cancerous tissue due to similar dens-
ities and high protein contents. In addition, movements
of the heart and mediastinum may be transmitted to the
target lesion, bringing them out of the focal zone.
Lung flooding seems to be ideal for HIFU application,
because sonographic imaging is possible and because of
other advantages.
Compared to other human tissues, a flooded lung has
an ideally suitable beam path, because water has a very
low attenuation. In contrast to flooded lung tissue, tumour
tissue converts acoustic energy into a therapeutic thermal
dose and enables selective heating of the cancer mass.
Consequently, damage to healthy lung tissue is minimised.
In addition to acoustic advantages, there are other
favourable conditions for tumour ablation in a flooded
lung. There is no pulmonary blood flow in a flooded lung
[22]. Perfusion reduces heat and is not desirable with
locoregional thermal therapy. In addition, ischaemia-
related acidosis sensitises tumour tissue to heat. In com-
parison to a ventilated lung, lung flooding reduces tumour
movements caused by breathing.
The following limitations existed in the current study.
The risk of lung flooding in patients with limited lung
function is unclear. Further studies on patients with
limited lung function should be performed to examine the
influence of unilateral lung flooding on haemodynamics
and gas exchange. Ongoing studies in pigs showed that
lung flooding of only one lobe is feasible.
Transcutaneous application was not applied for the
in vivo or ex vivo studies. One rib had to be resected to
apply the HIFU applicator, which consisted of a HIFU
transducer and sector-array probe, to the chest of a pig.
Technical improvements in the application system are
necessary to ensure that the HIFU focal zone is aimed
precisely at the target lesion with the guidance of sonog-
raphy. Transthoracic HIFU application is difficult despite
resection of the ribs, because the intercostal spaces in
the animal model are narrow. A method and transducers
have been developed to avoid the shielding of thera-
peutic ultrasound by the human rib cage [23].
Different HIFU exposure schemas (ten seconds ex vivo
versus ‘one second on/off ’ in vivo) and transducers were
applied during this study. Ultrasound imaging is dis-
turbed if HIFU is continuously on. Therefore, the inter-
mittent ‘one second on/off ’ in vivo schema was needed
to control the focal alignment with the thermocouple
during the ‘one second off ’ interval.
For HIFU application to human tumours, resected
lung lobes were used.
The gas-free filling occurs at 71.4% of the resected lobes.
This limitation is due to residual air in non-collapsed
bronchi that can only solved by resorption under in vivo
conditions [11]. Lung flooding was performed with cooledsaline at 15°C for the ex vivo HIFU application to ensure
that hypoxic damage did not occur within the tumour and
lung tissues. This was important, because the NADPH-
diaphorase staining method is based on mitochondrial
vitality, which is very sensitive to ischaemia.
A hyperechoic area was found within the tumour
tissue immediately following HIFU exposure. Grayscale
changes have been shown to be a useful marker for
HIFU-induced tissue destruction [8]. However, it is un-
clear whether the area of grayscale changes corresponds
with the ablated area, such that a hyperechoic sonolesion
represents irreversibly damaged tissue. B-mode ultrasound
imaging is probably not the best method for monitoring
tissue response. Currently, the most important problem
associated with ultrasound-guided HIFU ablation is the
lack of reliable thermometry and lesion production moni-
toring [6]. In addition to ultrasound imaging, real-time
magnetic resonance thermometry could be important for
ascertaining the extent of tumour destruction [24-26].
Conclusions
In combination with lung flooding, high-intensity focused
ultrasound produced a thermal effect in an ex vivo model
of human lung carcinoma and in simulated lung tumours
in an in vivo porcine model. High-intensity focused ultra-
sound is a potential strategy for treating lung cancer. Fur-
ther studies will examine HIFU therapy in animal models
of lung cancer.
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